• About Us
  • Contact Us
  • Advertise
  • Submissions
  • Comment Policy
  • Privacy Policy
  • Disclaimer

DRP Gazette

News From The Wall Street Grapevine
Menu
  • About Us
    • Contact Us
    • Privacy Policy
    • Advertise
    • Comment Policy

OTCMKTS:RVVTF Archive

5 OTC Foreign Stocks For You: SHNJF, RVVTF, RZREF, ALCUF, ORRCF, FITSF
News

5 OTC Foreign Stocks For You: SHNJF, RVVTF, RZREF, ALCUF, ORRCF, FITSF

May 18, 2022 | Ankit Singhania |
More
What’s Up with Revive Therapeutics Ltd. (OTCMKTS:RVVTF)
Biopharmacy, News

What’s Up with Revive Therapeutics Ltd. (OTCMKTS:RVVTF)

June 17, 2021 | Sean Dougherty |
More
Revive Therapeutics Ltd (OTCMKTS:RVVTF) Advancing Its Psilocybin Program With The Acquisition Of PharmaTher  Inc.
Marijuana

Revive Therapeutics Ltd (OTCMKTS:RVVTF) Advancing Its Psilocybin Program With The Acquisition Of PharmaTher Inc.

March 5, 2021 | Evan Dion |
More
Revive Therapeutics Ltd (OTCMKTS:RVVTF) Receives Approval For Phase 3 Clinical Study Of Bucillamine From FDA: Inks A Pact With AMS To Facilitate Trial To Treat COVID-19
Featured

Revive Therapeutics Ltd (OTCMKTS:RVVTF) Receives Approval For Phase 3 Clinical Study Of Bucillamine From FDA: Inks A Pact With AMS To Facilitate Trial To Treat COVID-19

September 3, 2020 | Caroline Biscotti |
More
Revive Therapeutics Ltd (OTCMKTS:RVVTF) Bets On Bucillamine, A Promising Treatment For Coronavirus: Preparing To Submit An IND With The FDA
Marijuana

Revive Therapeutics Ltd (OTCMKTS:RVVTF) Bets On Bucillamine, A Promising Treatment For Coronavirus: Preparing To Submit An IND With The FDA

June 30, 2020 | Evan Dion |
More
Copyright © 2025 DRP Gazette Theme by DRP Gazette
  • About Us
  • Advertise
  • Comment Policy
  • Contact Us
  • Disclaimer
  • Maison Luxe Inc (OTCMKTS:MASN) Stock Soars As Company All Set To Acquire Kicks On Demand
  • Privacy Policy
  • Submissions